EU Fast Track Review Sought For Avacincaptad Pegol, mRNA-1345 & Troriluzole
The European Medicines Agency is this week expected to consider whether the planned marketing applications for investigational products from Iveric Bio, Moderna and Biohaven merit an accelerated assessment.